Mathilde C M Kouwenhoven
Overview
Explore the profile of Mathilde C M Kouwenhoven including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
2415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Gaag S, Jordens T, Yaqub M, Grijseels R, van Valkengoed D, de Langen E, et al.
CPT Pharmacometrics Syst Pharmacol
. 2025 Feb;
PMID: 40009553
Osimertinib, a tyrosine kinase inhibitor (TKI), treats non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations. However, its efficacy may vary due to heterogeneous drug distribution, assessable...
2.
Vrancken Peeters N, Kerklaan R, Vlooswijk C, Bijlsma R, Kaal S, Tromp J, et al.
Qual Life Res
. 2025 Feb;
PMID: 39982594
Purpose: As the prognosis for adolescents and young adults (AYAs) with breast cancer has improved, long-term health-related quality of life (HRQoL) has become increasingly important. This study aimed to analyze...
3.
Reuvers M, Burgers V, Koekkoek J, Brandsma D, Compter A, Kouwenhoven M, et al.
Neurooncol Pract
. 2025 Feb;
12(1):113-121.
PMID: 39917748
Background: Low-grade gliomas (LGG) are among the most frequently occurring tumors in adolescent and young adult (AYA) patients (aged 18-39 years old at primary diagnosis). These tumors have a variable...
4.
Angoumis K, Padilla C, Kouwenhoven M, Bijlsma R, Kaal S, Tromp J, et al.
Support Care Cancer
. 2025 Jan;
33(2):95.
PMID: 39808329
Purpose: Adolescent and young adult (AYA) malignant brain tumour (BT) survivors are at risk of adverse health outcomes, which may impact their health-related quality of life (HRQoL). This study aimed...
5.
Janssen J, Brahm C, Driessen C, Nuver J, Labots M, Kouwenhoven M, et al.
Brain Commun
. 2024 Aug;
6(4):fcae241.
PMID: 39114330
Previously, the tyrosine kinase inhibitor sunitinib failed to show clinical benefit in patients with recurrent glioblastoma. Low intratumoural sunitinib accumulation in glioblastoma patients was reported as a possible explanation for...
6.
Janssen S, Vlooswijk C, Bijlsma R, Kaal S, Kerst J, Tromp J, et al.
J Cancer Surviv
. 2024 May;
PMID: 38740702
Background: With 5-year survival rates > 85%, gaining insight into the long-term and late health-related conditions of cancer survivors diagnosed in adolescence and young adulthood is of utmost importance to...
7.
Lehmann V, Vlooswijk C, van der Graaf W, Bijlsma R, Kaal S, Kerst J, et al.
J Cancer Surviv
. 2024 Feb;
PMID: 38316726
Purpose: To describe recall of fertility-related consultations and cryopreservation and to examine reproductive goals and reproduction post-treatment in long-term survivors of adolescent and young adult (AYA) (age, 18-39 years) cancer....
8.
Gavioli C, Vlooswijk C, Janssen S, Kaal S, Kerst J, Tromp J, et al.
J Cancer Surviv
. 2024 Jan;
PMID: 38224397
Purpose: For adolescent and young adult (AYA) cancer survivors with a good prognosis, having a healthy lifestyle prevents morbidity and mortality after treatment. The aim of this study was to...
9.
Bootsma T, van de Wal D, Vlooswijk C, Roos D, Drabbe C, Tissier R, et al.
Support Care Cancer
. 2024 Jan;
32(2):104.
PMID: 38217712
Purpose: Adolescent and young adult cancer survivors (AYAs) are at increased risk of long-term and late effects, and experience unmet needs, impacting their health-related quality of life (HRQoL). In order...
10.
Malta T, Sabedot T, Morosini N, Datta I, Garofano L, Vallentgoed W, et al.
Cancer Res
. 2023 Dec;
84(5):741-756.
PMID: 38117484
Significance: Standard treatments are related to loss of DNA methylation in IDHmut glioma, resulting in epigenetic activation of genes associated with tumor progression and alterations in the microenvironment that resemble...